Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | PIM1 | P11309 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24062420 | 0.81 | MGLL (0.53) | NR1H2MGLLMAPK1MAPT | |
| SCHEMBL18542343 | 0.79 | CYP1A2 (0.44) | MGLLPIM1KMT2AMEN1TDP1 | |
| SCHEMBL22166357 | 0.78 | AHR (0.47) | PIM1KMT2AMEN1TDP1AHR | |
| SCHEMBL28934572 | 0.78 | PIM1 (0.45) | PIM1KMT2AMEN1TDP1AHR | |
| SCHEMBL18542432 | 0.76 | MGLL (0.39) | NR1H2MGLLMAPK1MAPT | |
| SCHEMBL25625962 | 0.76 | PIM1 (0.46) | PIM1KMT2AMEN1TDP1AHR | |
| SCHEMBL18542359 | 0.75 | PLA2G2A (0.40) | NR1H2MGLLKMT2AMEN1KDM4E | |
| SCHEMBL29405389 | 0.74 | OPRK1 (0.39) | MGLLPIM1KMT2AMEN1TDP1 | |
| SCHEMBL28702702 | 0.74 | OPRK1 (0.39) | MGLLPIM1KMT2AMEN1TDP1 | |
| SCHEMBL18542407 | 0.74 | MGLL (0.37) | NR1H2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3334731-B1 | PHENOXAZINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-03-03 | — | — | EP | disclosed |
| US-10696664-B2 | Phenoxazine derivatives for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2020-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696664-B2 | Phenoxazine derivatives for organic electroluminescent devices | TYR, PPOX, SLCO2A1 | NR1H2 2274/4885MGLL 4147/4885PIM1 2702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.